SOLV240719P50000
- 0.99
- +0.19+23.75%
Solventum Newsroom
U.S. News & World Report Expands Use of Solventum's Ambulatory Potentially Preventable Complications Grouping Software for Use in Its 2024-2025 Best Hospitals Rankings
ST. PAUL, Minn., July 2, 2024 /PRNewswire/ -- Solventum today announced that U.S. News & World Report is expanding its use of Solventum's 3M Ambulatory Potentially Preventable Complications (AM-PPCs)
The New York Stock Exchange Leads Industry in Global IPO Proceeds for the First Half of 2024
NYSE issuers raise $12 billion as IPO activity builds momentum Welcomes 7 of the 10 largest U.S. transactions The Big Board continues to drive exchange transfers The New York Stock Exchange, part of
Insulet Tops S&P 500 Growth Chart for Q2 as It Gains Market Share in the Diabetes Space
Retail Investors Who Have a Significant Stake Must Be Disappointed Along With Institutions After Solventum Corporation's (NYSE:SOLV) Market Cap Dropped by US$358m
Key Insights The considerable ownership by retail investors in Solventum indicates that they collectively have a greater say in management and business strategy The top 25 shareholders own 41% of th
Should You Be Excited About Solventum Corporation's (NYSE:SOLV) 33% Return On Equity?
Solventum Is Maintained at Neutral by B of A Securities
Solventum Is Maintained at Neutral by B of A Securities
B of A Securities Maintains Neutral on Solventum, Lowers Price Target to $60
B of A Securities analyst Travis Steed maintains Solventum (NYSE:SOLV) with a Neutral and lowers the price target from $70 to $60.
Solventum Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/25/2024 17.17% B of A Securities $70 → $60 Maintains Neutral 05/30/2024 5.45% Goldman Sachs → $54 Initi
Bottom 10 Performing S&P 500 Names as H1 Looks to Close Out This Week
BofA Securities Maintains Solventum(SOLV.US) With Hold Rating, Cuts Target Price to $60
BofA Securities analyst Travis Steed maintains $Solventum(SOLV.US)$ with a hold rating, and adjusts the target price from $70 to $60.According to TipRanks data, the analyst has a success rate of 60.6%
Express News | Solventum Corp : BofA Global Research Cuts Price Objective to $60 From $70
10 Health Care Stocks Whale Activity In Today's Session
This whale alert can help traders discover the next big trading opportunities.Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scan
Solventum Introduces Denials Prevention Solution, an AI-powered Tool, Empowering Health Systems to Help Reduce Write-offs and Improve Top Line Revenue
ST. PAUL, Minn., June 24, 2024 /PRNewswire/ -- Solventum (NYSE: SOLV), [formerly 3M Health Care] today announced a new artificial intelligence (AI)-driven payment integrity and revenue cycle solution
Argus Research Initiates Solventum(SOLV.US) With Hold Rating
Argus Research analyst David Toung initiates coverage on $Solventum(SOLV.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 63.1% and a total average return of 9.4%
Argus Research Initiates Solventum at Hold Rating
07:55 AM EDT, 06/24/2024 (MT Newswires) -- Argus Research Initiates Solventum at Hold Rating Price: 52.50, Change: +0.15, Percent Change: +0.29
Unusual Options Activity: SOLV, SE and Others Attract Market Bets, SOLV V/OI Ratio Reaches 129.2
EST Jun 18th Morning Delivery - In the last two hours of trading, 10 options with a high V/OI ratio were detected. With the market volatile, it's crucial to stay informed on the latest options trends.
Top 10 Worst S&P Performers Over the Past 1-month
Wells Fargo Maintains Solventum(SOLV.US) With Hold Rating
Wells Fargo analyst Vik Chopra maintains $Solventum(SOLV.US)$ with a hold rating.According to TipRanks data, the analyst has a success rate of 20.7% and a total average return of -13.4% over the past
Express News | Solventum received an unsolicited mini-tender offer proposal from TRC Capital to purchase up to 2 million shares of common stock at a price of $59.15 per share.
Express News | Solventum - Notified That Trc Capital Investment Made Unsolicited Mini-Tender Offer to Purchase up to 2 Mln Shares of Common Stock at $59.15 per Share